Use of desethyl-N-acetylprocainamide (NAPADE) as an inotropic ag

Details Use of desethyl-N-acetylprocainamide (NAPADE) as an inotropic ag Use of desethyl-N-acetylprocainamide (NAPADE) as an inotropic ag

1984-08-31

1985-11-26

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Nitrogen containing other than solely as a nitrogen in an...

A61K 3116

Patent

active

045555257

ABSTRACT:
Heart failure and other heart abnormalties are treated with the inotropic agent desethyl-N-acetylprocainamide (NAPADE).

REFERENCES:
patent: 4420568 (1983-12-01), Wang et al.
Ruo et al., Therapeutic Drug Monitoring 3: 231-237, 1981 (not attached).
Ruo et al., J. of Phar. and Ex. Ther., 216: 357-362, 1981 (not attached).
Goodman and Gilman: The Pharmacological Basis of Therapeutics, 5th Ed., MacMillan Pub., Chap. 32, pp. 683-704.

Affiliated with

Also associated with

Rating

Use of desethyl-N-acetylprocainamide (NAPADE) as an inotropic ag does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of desethyl-N-acetylprocainamide (NAPADE) as an inotropic ag, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of desethyl-N-acetylprocainamide (NAPADE) as an inotropic ag will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-270091